Literature DB >> 15681472

Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner.

Mansour Akbari1, Marianne Doré Hansen, Jostein Halgunset, Frank Skorpen, Hans E Krokan.   

Abstract

Paraffin-embedded tissue is an important source of material for molecular pathology and genetic investigations. We used DNA isolated from microdissected formalin-fixed, paraffin-embedded gastric tumors for mutation analysis of a region of the human gene for uracil-DNA glycosylase (UNG), encoding the UNG catalytic domain, and detected apparent base substitutions which, after further investigation, proved to be polymerase chain reaction (PCR) artifacts. We demonstrate that low DNA template input in PCR can generate false mutations, mainly guanine to adenine transitions, in a sequence-dependent manner. One such mutation is identical to a mutation previously reported in the UNG gene in human glioma. This phenomenon was not caused by microheterogeneity in the sample material because the same artifact was seen after amplification of a homogenous, diluted plasmid. We did not observe genuine mutations in the UNG gene in 16 samples. Our results demonstrate that caution should be taken when interpreting data from PCR-based analysis of somatic mutations using low amounts of template DNA, and that methods used to enrich putative subpopulations of mutant molecules in a sample material could, in essence, be a further amplification of sequence-dependent PCR-generated artifacts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681472      PMCID: PMC1867510          DOI: 10.1016/s1525-1578(10)60006-2

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  17 in total

1.  Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability.

Authors:  Kathryn Farrand; Lydija Jovanovic; Brett Delahunt; Bryan McIver; Ian D Hay; Norman L Eberhardt; Stefan K G Grebe
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

2.  PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases.

Authors:  J Cline; J C Braman; H H Hogrefe
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

Review 3.  Uracil in DNA--occurrence, consequences and repair.

Authors:  Hans E Krokan; Finn Drabløs; Geir Slupphaug
Journal:  Oncogene       Date:  2002-12-16       Impact factor: 9.867

4.  Human uracil-DNA glycosylase gene: sequence organization, methylation pattern, and mapping to chromosome 12q23-q24.1.

Authors:  T Haug; F Skorpen; K Kvaløy; I Eftedal; H Lund; H E Krokan
Journal:  Genomics       Date:  1996-09-15       Impact factor: 5.736

5.  Sequence variation in the human uracil-DNA glycosylase (UNG) gene.

Authors:  K Kvaløy; H Nilsen; K S Steinsbekk; A Nedal; B Monterotti; M Akbari; H E Krokan
Journal:  Mutat Res       Date:  2001-01-05       Impact factor: 2.433

6.  Hypermutable bases in the p53 cancer gene are at vulnerable positions in DNA secondary structures.

Authors:  Barbara E Wright; Jacqueline M Reimers; Karen H Schmidt; Dennis K Reschke
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

7.  Multiplex loss of heterozygosity analysis by using single or very few cells.

Authors:  Xiangfeng Cui; Helen Feiner; Honghua Li
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

8.  Mutation of the uracil DNA glycosylase gene detected in glioblastoma.

Authors:  Y W Moon; W S Park; A O Vortmeyer; R J Weil; Y S Lee; T A Winters; Z Zhuang; B G Fuller
Journal:  Mutat Res       Date:  1998-11-03       Impact factor: 2.433

9.  In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR.

Authors:  Nancy Quach; Myron F Goodman; Darryl Shibata
Journal:  BMC Clin Pathol       Date:  2004-02-12

10.  Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.

Authors:  Kohsuke Imai; Geir Slupphaug; Wen-I Lee; Patrick Revy; Shigeaki Nonoyama; Nadia Catalan; Leman Yel; Monique Forveille; Bodil Kavli; Hans E Krokan; Hans D Ochs; Alain Fischer; Anne Durandy
Journal:  Nat Immunol       Date:  2003-09-07       Impact factor: 25.606

View more
  37 in total

1.  Rapid, sequence-specific detection of unpurified PCR amplicons via a reusable, electrochemical sensor.

Authors:  Rebecca Y Lai; Eric T Lagally; Sang-Ho Lee; H T Soh; Kevin W Plaxco; Alan J Heeger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-03       Impact factor: 11.205

2.  Non-reproducible sequence artifacts in FFPE tissue: an experience report.

Authors:  Richard Ofner; Cathrin Ritter; Selma Ugurel; Lorenzo Cerroni; Mathias Stiller; Thomas Bogenrieder; Flavio Solca; David Schrama; Jürgen C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-17       Impact factor: 4.553

3.  Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors.

Authors:  Karolina Edlund; Ola Larsson; Adam Ameur; Ignas Bunikis; Ulf Gyllensten; Bernard Leroy; Magnus Sundström; Patrick Micke; Johan Botling; Thierry Soussi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-24       Impact factor: 11.205

Review 4.  Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.

Authors:  George Miles; James Rae; Suresh S Ramalingam; John Pfeifer
Journal:  Semin Oncol       Date:  2015-07-14       Impact factor: 4.929

5.  Targeted deep sequencing reveals no definitive evidence for somatic mosaicism in atrial fibrillation.

Authors:  Jason D Roberts; James Longoria; Annie Poon; Michael H Gollob; Thomas A Dewland; Pui-Yan Kwok; Jeffrey E Olgin; Rahul C Deo; Gregory M Marcus
Journal:  Circ Cardiovasc Genet       Date:  2014-11-18

6.  The Core/E1 domain of hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma.

Authors:  Xiaoan Zhang; Soo Hyung Ryu; Yanjuan Xu; Tamerl Elbaz; Abdel-Rahman N Zekri; Ashraf Omar Abdelaziz; Mohamed Abdel-Hamid; Valerie Thiers; Santiago F Elena; Xiaofeng Fan; Adrian M Di Bisceglie
Journal:  J Clin Virol       Date:  2011-09-17       Impact factor: 3.168

Review 7.  The role of replicates for error mitigation in next-generation sequencing.

Authors:  Kimberly Robasky; Nathan E Lewis; George M Church
Journal:  Nat Rev Genet       Date:  2013-12-10       Impact factor: 53.242

8.  Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissue.

Authors:  Elisa Carturan; David J Tester; Brian C Brost; Cristina Basso; Gaetano Thiene; Michael J Ackerman
Journal:  Am J Clin Pathol       Date:  2008-03       Impact factor: 2.493

9.  Mutation detection by real-time PCR: a simple, robust and highly selective method.

Authors:  John Morlan; Joffre Baker; Dominick Sinicropi
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

10.  Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.

Authors:  Hongdo Do; Alexander Dobrovic
Journal:  Mol Cancer       Date:  2009-10-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.